Prostate Cancer - Results from #26000

Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: A large cohort study - Abstract May 2, 2012

Concordance of tumor differentiation among brothers with prostate cancer - Abstract May 2, 2012

Germline predictors of androgen deprivation therapy response in advanced prostate cancer - Abstract May 2, 2012

Factors affecting health-related quality of life in prostate cancer patients - Abstract May 2, 2012

Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer - Abstract May 1, 2012

Is prostate biopsy essential to diagnose prostate cancer in the older patient with extremely high prostate-specific antigen? - Abstract May 1, 2012

Software-controlled, highly automated intrafraction prostate motion correction with intrafraction stereographic targeting: System description and clinical results - Abstract May 1, 2012

Incidence of prostate cancer in Lithuania after introduction of the Early Prostate Cancer Detection Programme - Abstract May 1, 2012

Prostate cancer vaccines: Moving therapeutic vaccination forward in the post-Provenge era - Abstract May 1, 2012

Clinical and pathological parameters predicting extracapsular disease in patients undergoing a radical prostatectomy for clinically localized prostate cancer - Abstract May 1, 2012

Image-guided radiation therapy - Abstract May 1, 2012

Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy - Abstract April 30, 2012

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer - Abstract April 30, 2012

Therapeutic options for advanced prostate cancer: 2011 Update - Abstract April 30, 2012

Prostate cancer chemoprevention by soy isoflavones: Role of intestinal bacteria as the "second human genome" - Abstract April 30, 2012

Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): A new risk factor for prostate cancer - Abstract April 30, 2012

Periprostatic lymph node metastasis in prostate cancer and its clinical significance - Abstract April 30, 2012

Decision-making process reported by Medicare patients who had coronary artery stenting or surgery for prostate cancer - Abstract April 27, 2012

Blood cells and their use in active immunotherapy of prostate cancer - Abstract April 27, 2012

Understanding fragmentation of prostate cancer survivorship care: Implications for cost and quality - Abstract April 27, 2012

Page 1301 of 1437